Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine
Despoina Aslanoglou, Suzanne Bertera, Laura Friggeri, Marta Sánchez‐Soto, Jeongkyung Lee, Xiangning Xue, Ryan W. Logan, J. Robert Lane, Vijay Yechoor, Peter J. McCormick, Jens Meiler, R. Benjamin Free, David R. Sibley, Rita Bottino, Zachary Freyberg
Abstract
-AR and D2R. Together, joint dopaminergic and adrenergic receptor actions on α-cell and β-cell hormone release provide a new therapeutic mechanism to improve dysglycemia.
Topics & Concepts
BromocriptineDopaminergicDopamine receptor D2DopamineStimulationReceptorEndocrinologyDopamine receptorInternal medicineChemistryPharmacologyMedicineHormoneProlactinPancreatic function and diabetesReceptor Mechanisms and SignalingDiabetes Treatment and Management